ArticleCell death & disease2026

Dihydroartemisinin inhibits mutant KRAS to potentiate regorafenib plus anti-PD-1 in KRAS-mutant colorectal cancer liver metastases.

Ning Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.